Why Nifty Pharma Fell Today: Trump's Generic Drug Tariff Plan Sparks Selling in Pharma Stocks
President Trump announced imported generic medicines will have 0% tariff for two years, then 100% in year three, and 200% from year four onward.
Nifty Pharma index fell 1.31% on the day of the announcement.
Indian pharma companies like Sun Pharma, Lupin, Cipla, Dr. Reddy's, and Aurobindo Pharma saw declines of up to 4%.
The U.S. is the largest export market for Indian pharma, with nearly $9.7 billion in annual exports, mainly generics.
Investors fear higher tariffs will erode cost advantage, reduce exports, and compress margins for Indian firms.
Story angle
Center
Near the middle: closer to straight reporting, less party-line spin.
About how the story is framed, not whether the facts are true.
Dalal Street Investment Journal
Center
Mixed factuality
Who owns this?
DSIJ Pvt Ltd
Independent markets publisher